Genes, ancestry and metabolism: why not everyone needs the same diet
Evolution has adapted metabolism to very different menus. What of that is documented, what follows from it for you and why the answer in the end does not lie in your family tree.
More guides from the nutrition cluster
I see in my consultations that people react very differently to the same food. Taking that observation seriously without turning it into a law is the balancing act of this text. Evolutionary genetics has found real adaptations. They just say something about populations and almost nothing about you.
Two colleagues sit in the same office kitchen in the morning. Both eat the same thing: a roll with jam and a coffee. One works with full focus until lunch. The other sits there at half past ten and feels as if someone had pulled the plug.
Both are healthy. Both slept about the same. Both ate the same thing.
You probably know this scene. Maybe from your partner, who can eat pasta like a marathon runner while one plate of it sends you into an afternoon nap. And at some point comes the question I am asked often in my practice: is this about where I come from?
The answer has two halves. First: yes, evolution has adapted metabolism to very different menus, and we can read that in the genome. Second: no, so far nothing follows from it that gives you a personal eating plan. Both halves belong together.
What to expect here
- How large the differences between people after identical meals turned out to be
- Why the salivary amylase gene AMY1 is the finest example of adaptation to the plate
- Milk tolerance as the exception, not the default
- CPT1A and TBC1D4: the strongest Arctic findings, honestly placed
- FADS1 and FADS2: why some people can build more EPA themselves
- ALDH2, MTHFR and APOE4 in a direct comparison of evidence
- Why ancestry is a hypothesis and not a finding
- What two large studies on DNA diet tests found
- What actually is individual instead
The same meal, two very different curves
Nutrition counselling carries a quiet assumption: a food has a value, and that value holds for everyone. The glycaemic index sits in tables as if it were a property of the apple. But it is also a property of the person eating it.
Since glucose sensors exist, this can be measured. The numbers are more striking than I had expected.
An Israeli research group around David Zeevi had 800 people measure their blood sugar for a week and recorded almost 47,000 everyday meals.
The response to identical meals varied considerably between participants. A model built from blood values, diet, activity and gut microbiome hit the personal curve better than carbohydrate content alone. The randomised phase was small, more a proof of feasibility than a clinical proof.
For you this means: the same banana is not the same banana in two different people.
Zeevi D et al. Cell. 2015. DOI: 10.1016/j.cell.2015.11.001 · PMID: 26590418 [Cohort, n=800]A British team around Sarah Berry studied 1,002 twins and unrelated adults, plus 100 people in a US group, each after standardised test meals.
The coefficient of variation between people was 103 percent for triglycerides and 68 percent for glucose. Genetic variants contributed only a little to the prediction: 9.5 percent for the glucose response, 0.8 percent for the triglycerides.
For you this means: the difference between people is huge, and genes explain a small part of it.
Berry SE et al. Nat Med. 2020. DOI: 10.1038/s41591-020-0934-0 · PMID: 32528151 [Cohort, n=1,002]I see a pattern in my consultations: people whose families come from regions near the equator often seem to me to get along better with starch rich food. People from regions near the poles come across to me more often as fat oriented.
That is an observation, not a finding. What the literature supports is narrower. It documents single adaptations in single populations, no compass direction rule. I am telling you both: what has been found, and where my observation runs ahead of the data.
The common question is: which metabolic type am I? It assumes that types exist. I find this more useful: how large is my response to a particular meal, and what shifts it?
The first path ends at a category, the second at a measurable curve you can influence. More on this in the article Why a calorie in the body is not a calorie.
That leaves the question of where this spread comes from. Part of it does sit in the genome.
Starch: the amylase gene as an adaptation to the plate
Chew a piece of white bread long enough without swallowing. It turns sweet. That is chemistry: your saliva carries amylase, an enzyme that breaks long starch chains into short sugar units. Digestion begins in the mouth.
What is special about the gene behind it: it does not come in two copies as usual. In some people there are one or two, in others more than ten. As in a supermarket, with the same crowd it makes a difference whether two or twelve checkouts are open.
George Perry and colleagues compared AMY1 copy number in populations with traditionally starch rich and with traditionally starch poor diets.
Copy number correlated with the amylase content in saliva. Groups with starch rich food had more copies on average, and the differences were more pronounced than at comparable gene loci, a hint of positive selection.
For you this means: how early your body opens up starch is partly inherited and connected to what your ancestors ate.
Perry GH et al. Nat Genet. 2007. DOI: 10.1038/ng2123 · PMID: 17828263 [Overview]Abigail Mandel and Paul Breslin sorted healthy adults by their salivary amylase activity into two groups of seven people each.
After a starch solution the group with high amylase had lower blood sugar values at 45, 60 and 75 minutes and a lower peak. After pure glucose solution there was no difference, which fits the mechanism.
For you this means: the effect is plausible. With 14 people the study is very small, so it is a hint and not a proof.
Mandel AL, Breslin PAS. J Nutr. 2012. DOI: 10.3945/jn.111.156984 · PMID: 22492122 [RCT, n=14]And now comes the part that test providers rarely mention. In 2014 a paper appeared reporting that a low AMY1 copy number goes along with a higher obesity risk, calculated as roughly an eightfold difference between the top and the bottom tenth. That was the birth of many reports about the carbohydrate type.
A year later another group measured the same locus again with better technology. With sufficient statistical power the link with body weight could not be confirmed. A Mexican paper in 597 children found the original pattern again, but it remained an association study.
A spectacular gene and nutrition finding can fall apart within a year when someone measures more precisely. That is not a failure of science. That is science.
For a test that turns it into a recommendation for your dinner it is still a problem. The test stays in circulation even when the study behind it no longer stands.
What remains is the adaptation story, and it is strong: starch digestion begins in the mouth, and how vigorously it begins there has a long prehistory.
Milk: an adaptation that arose independently more than once
Most people can no longer digest milk sugar as adults. That turns our sense of normal upside down. In mammals, switching off lactase production after weaning is the default. The exception is to keep producing this enzyme for a lifetime.
Picture a light switch that goes off in almost all mammals after weaning. In some humans it is jammed and stays on. Not because they are healthier, but because their ancestors had milk available.
Sarah Tishkoff and her team examined 470 people from Tanzania, Kenya and Sudan for the ability to digest lactose as adults.
They found three new variants in the regulatory region of the lactase gene, on different haplotype backgrounds than the known European variant. The long, barely interrupted haplotype block points to a rapid spread within roughly the last 7,000 years. The evidence for increased transcription came from cell culture.
For you this means: the same ability arose independently in Europe and in Africa, in each case where people kept livestock.
Tishkoff SA et al. Nat Genet. 2007. DOI: 10.1038/ng1946 · PMID: 17159977 [Overview] with an [In vitro] componentHow strong this signal is shows in a paper by Tal Bersaglieri. In samples of northern European descent the associated alleles mark a haplotype at about 77 percent that runs almost uninterrupted over more than one million bases. The authors call it one of the strongest selection signals in the human genome, arising within the last 5,000 to 10,000 years.
Diet can reshape genes within a few thousand years. The interesting question is whether that means anything for your breakfast tomorrow.
The thread running through this articleAnd then the neat story became complicated. In 2022 Richard Evershed and a large team analysed around 7,000 fat residues from pottery at more than 550 sites to map milk use across 9,000 years.
The result did not match the expectation. A selection model following the intensity of milk use explained the allele frequencies no better than a model with steady selection. In the UK Biobank the genotype was only weakly linked to milk consumption. As a hypothesis the authors propose periods of famine and disease burden. A review by Laure Ségurel and Céline Bon names further open contradictions, such as low frequencies among Central Asian herding peoples.
Even the textbook example of gene and culture coevolution is not fully explained. Anyone who says the genetics of nutrition is settled is simplifying.
For everyday life the consequence is pleasantly simple: milk intolerance in this sense is not an illness and not a flaw. It is the more common variant of being human.
That makes it clear why tolerance here is the exception and not the rule.
The Arctic: when carbohydrates become metabolically expensive
If there is a documented case in which a population is genetically set up for a very fat rich diet, it is in the Arctic. And this very case shows most clearly why no recommendation follows from it.
Florian Clemente and colleagues narrowed down a striking region on chromosome 11 in northeast Siberian populations using high coverage whole genome data.
The most likely variant lies in the gene CPT1A, the doorkeeper for the entry of long chain fatty acids into the mitochondria. It reaches 68 percent in the northeast Siberian sample and is also common among Canadian and Greenlandic Inuit. At the same time it is associated with hypoglycaemia without ketone formation and with increased infant mortality.
For you this means: a variant can spread and still carry disadvantages. Common is not the same as good.
Clemente FJ et al. Am J Hum Genet. 2014. DOI: 10.1016/j.ajhg.2014.09.016 · PMID: 25449608 [Overview]Ida Moltke and a Danish and Greenlandic team studied up to 2,575 people in Greenland, complemented by muscle biopsies.
They found a variant in the gene TBC1D4 with an allele frequency of 17 percent. Homozygous carriers had blood sugar values 3.8 mmol/L higher two hours after a glucose load, and the odds ratio for type 2 diabetes was 10.3. In muscle there was less GLUT4, meaning fewer doors for sugar transport.
For you this means: there are groups for whom a carbohydrate rich diet is metabolically more expensive, in an order of magnitude that no diet and gene combination has ever reached.
Moltke I et al. Nature. 2014. DOI: 10.1038/nature13425 · PMID: 25043022 [Cohort, n=2,575]A third finding fits with this. Matteo Fumagalli and colleagues searched the genomes of Greenlandic Inuit for selection signals. The strongest lay at the fatty acid desaturases, the enzymes for polyunsaturated fatty acids. The selected alleles were connected to weight and body height.
These findings do not mean that people with Arctic ancestry benefit from a fat richer diet today. The data do not carry that bridge. The CPT1A variant is disadvantageous when looked at on its own, and the TBC1D4 variant describes a risk.
The famous story that Greenlandic Inuit had almost no heart attacks because of their fat rich food has also not held up on examination. George Fodor and colleagues showed that the original papers from the 1970s had not investigated coronary heart disease at all.
Population genetics does not tell hero stories, it tells trade-offs. A variant spreads because in a particular environment it helps more than it harms. Change the environment and the arithmetic changes.
That is why I speak here about gene variants and their frequencies, not about groups of people. A frequency of 68 percent also means that 32 percent do not carry the variant.
And now you see why the strongest finding in this article of all things yields no recipe.
Omega-3: why some people can build more EPA themselves
You may have heard that linseed oil is not enough as an omega-3 source because the body converts the plant precursor into EPA and DHA only poorly. That is true in principle. What is rarely added: how poorly this conversion runs differs from person to person.
Two neighbouring genes are responsible, FADS1 and FADS2. They encode the enzymes that form the bottleneck of this conversion chain. Picture a workshop: the number and the speed of the machines decide the output.
Adam Ameur and a European consortium examined the FADS region in five cohorts with 5,652 genotyped people.
They found two common haplotypes that differ strongly in how efficiently they build long chain polyunsaturated fatty acids. The more efficient one arose after the split between the modern human lineage and Neanderthals and shows signs of positive selection.
For you this means: how much EPA you can build yourself from plant precursors hangs on a variant that not everyone carries.
Ameur A et al. Am J Hum Genet. 2012. DOI: 10.1016/j.ajhg.2012.03.014 · PMID: 22503634 [Cohort, n=5,652]How different the frequencies are was studied by Kumar Kothapalli. A regulatory polymorphism in FADS2 that favours endogenous conversion was present at 68 percent in a largely vegetarian Indian sample compared with 18 percent in a US sample. Calculated globally: around 70 percent in South Asian, 53 in African, 29 in East Asian and 17 percent in European samples.
And the direction of selection was not the same everywhere. Michael Buckley compared FADS data from present-day and Bronze Age Europeans: in Europe other alleles were selected than in South Asia or Greenland, with the opposite effect on the fatty acid profile. A paper by Iain Mathieson on ancient DNA from 230 West Eurasians shows in general that diet related gene loci are among the most striking targets of selection.
There is no single correct fatty acid metabolism. Evolution has pushed it in different directions in different world regions, depending on what was on the plate.
Something modest but useful follows from this in practice. If you eat vegetarian or vegan, do not rely on your own conversion being enough. Whether it is enough is not visible in your family tree but in the omega-3 index in your blood. The physiology is in the article ALA, EPA and DHA, the question of sources in the article Omega-3 from plants and animals.
And with that you know why two people with the same intake do not have to end up with the same blood value.
Alcohol, folate, cholesterol: three variants, three levels of evidence
Up to here this was about adaptation across millennia. Now it gets more concrete. Some gene variants do play a role in everyday life, but the evidence behind them differs a lot in strength.
ALDH2 and the facial flush after a glass of wine
Alcohol is first broken down into acetaldehyde. If the enzyme aldehyde dehydrogenase 2 works more slowly, this intermediate can build up, blood vessels can widen and the face turns red. A review by Philip Brooks places this flush reaction as a visible marker for a clearly increased risk of oesophageal cancer with alcohol consumption. The consequence here is comparatively clear, and it concerns alcohol, not the macronutrients.
MTHFR and folate metabolism
Hardly any gene variant has made such a career on the internet. The American professional society for medical genetics published a guideline in 2013: within a thrombophilia workup, MTHFR testing should not be carried out routinely, because newer meta-analyses did not confirm the assumed connections. That applies to clotting questions and not to nutrition in general, but it shows how far a popular narrative and a professional assessment can drift apart.
APOE4 and fat metabolism
Here there is a real gene and diet interaction, and it is small. In a secondary analysis of the British RISCK study with 389 evaluated people, total cholesterol and apolipoprotein B fell more in carriers of the E4 variant when saturated fats were replaced by carbohydrates with a low glycaemic index, by 0.28 mmol/L over 24 weeks. The genotype was determined afterwards, and the endpoints are laboratory values. More on this in the article Cholesterol and what the science shows.
| Variant | What is well documented | What follows from it for you |
|---|---|---|
| ALDH2 | Flush reaction as a marker for slowed acetaldehyde breakdown, increased risk of oesophageal cancer with alcohol consumption | A clear, practically usable piece of information. Visible without a test. |
| MTHFR | Professional society advises against routine testing within a thrombophilia workup | A test result alone does not justify high dose supplementation. |
| APOE4 | Secondary analysis with a diet and genotype interaction in lipid values over 24 weeks | Real, but small. No individual recommendation can be derived. |
| AMY1 | Copy number correlates with salivary amylase and the traditional menu | Interesting for understanding, without a practical consequence for testing. |
What decides is not the question of whether a gene variant exists. It is the question of how large its effect is and whether an action follows from it.
You recognise a variant with a clear consequence by the fact that professional societies talk about it. For most nutrition SNPs they do not, and for good reason.
And with that you have a grid for every future gene variant headline.
Why ancestry is still not a set of dietary instructions
Now comes the section I consider the most important. This is where the discussion regularly slips, either into determinism or into a complete shrug.
The first reason is statistical. Noah Rosenberg and colleagues studied 1,056 people from 52 populations at 377 gene loci. 93 to 95 percent of genetic variation lies between individuals within a population, only 3 to 5 percent between the large geographic groups. Two people from the same region can be genetically further apart than two people from different continents.
The second reason held me back the most. The best known ancestry and metabolism pattern is the increased diabetes risk among South Asian migrants: illness typically five to ten years earlier and at a lower BMI.
Naveed Sattar and Jason Gill summarised in a large review what lies behind this pattern.
Contributing factors are a higher body fat percentage with more visceral fat, less lean mass and lower cardiorespiratory fitness. The authors state explicitly that there is no clear evidence for a substantial genetic contribution.
For you this means: in the best known pattern of all, the explanation lies not in the genes but in body composition, fitness and life course.
Sattar N, Gill JMR. Lancet Diabetes Endocrinol. 2015. DOI: 10.1016/S2213-8587(15)00326-5 · PMID: 26489808 [Systematic Review]In 2004 the WHO therefore made a remarkably cautious decision. An expert consultation examined separate BMI cut-offs for Asian populations. The threshold for observed increased risk lay between 22 and 25 depending on the population. Instead of a new number for everyone, additional points for action were proposed at 23.0, 27.5, 32.5 and 37.5.
A meta-analysis by Keiichi Kodama across 74 cohorts with 3,813 people fits with this: insulin sensitivity and insulin response sit at different points on the same curve in different groups. The authors suspect a genetic background but did not measure any genetic markers.
And finally the part of metabolism that has the most direct connection to eating. Daphna Rothschild analysed data from 1,046 people with very different ancestries living in a shared environment. The gut microbiome was not significantly linked to ancestry. In contrast, the microbiomes of unrelated people sharing a household resembled each other.
There is no clean north to south gradient in carbohydrate metabolism. The documented examples concern single populations and single gene loci, not compass directions. FADS selection in Europe even ran in the opposite direction to the Inuit.
What remains of my observation is a hypothesis that can be useful in conversation. It makes it possible to ask at all, instead of recommending the same standard diet to everyone. As a justification for an eating plan it does not hold.
Ancestry is a hypothesis, not a finding. It can open a question. It cannot answer one.
And one more thing matters to me: this is about gene variants and their frequencies, not about people and how they look. Inferring a metabolism from a face is medically untenable and humanly out of order.
And that is why the next question is the right one: if ancestry reveals nothing, can a gene test at least do it?
What DNA diet tests promise and what has been examined
On the providers' websites it sounds convincing. You spit into a tube and after a few weeks you get a classification: fat burner, carbohydrate burner or mixed type, plus a nutrient distribution in percent. The price is usually between 150 and 300 euros.
I searched specifically for the primary literature that defines and examines this three way split. I did not find it. As far as I can trace it, the categories come from marketing and not from the specialist literature. That does not automatically mean they are wrong. It means that nobody has tested them robustly so far.
What has been examined is the core claim behind them: that the genotype predicts which diet works better for you.
Christopher Gardner and his team randomised 609 adults with a BMI between 28 and 40 over twelve months to a healthy low fat or a healthy low carbohydrate diet. Three genotype patterns were defined in advance.
After twelve months the weight change was minus 5.3 kg versus minus 6.0 kg, a difference of 0.7 kg. Neither genotype pattern nor insulin secretion predicted success, and the interaction was at p=0.20.
For you this means: exactly the core claim of such tests was cleanly examined here and could not be confirmed.
Gardner CD et al. JAMA. 2018. DOI: 10.1001/jama.2018.0245 · PMID: 29466592 [RCT, n=609]Carlos Celis-Morales and a European consortium randomised adults from seven countries to conventional or to personalised advice, graded by diet, by diet plus phenotype, or additionally by five gene variants.
After six months those who received personalised advice ate less red meat, less salt and less saturated fat. Adding phenotype or genotype brought no discernible additional benefit beyond that.
For you this means: personal advice can make a difference. The genotype was not the effective ingredient in it.
Celis-Morales C et al. Int J Epidemiol. 2017. DOI: 10.1093/ije/dyw186 · PMID: 27524815 [RCT, n=1,269]This criticism does not come from outside. A group of authors from nutrigenetics itself stated in 2017 that the field is unregulated and that beyond commercial codes of practice no defined standards exist. A review by Dong Wang and Frank Hu names a lack of reproducibility and the still missing proof of additional benefit compared with classical nutrition intervention.
I am not saying that nutrigenetics is nonsense. I consider it one of the most exciting fields of the coming years. From my point of view it is simply not yet at the stage where a reliable dietary recommendation can be bought from it.
The distance between a promising research field and a market ready product is exactly the place where many providers turn off too early.
That leaves the question of what works instead.
Measure instead of guess: the path that really is individual
If you have read this far, a slightly frustrating feeling may have set in. The differences are real, the genes barely explain them, and your family tree explains them even less. What is left?
Quite a lot. Just not from the laboratory of the past, but from your own body.
Tuomas Kilpeläinen and colleagues pooled 45 adult studies and 9 studies in children with a total of 218,166 adults to examine the effect of the best known obesity gene variant FTO.
In physically active adults the link between the variant and obesity risk was 27 percent weaker, and the interaction was statistically clear. In children and adolescents this was not found.
For you this means: a genotype describes a tendency. Lifestyle can shift that tendency measurably.
Kilpeläinen TO et al. PLoS Med. 2011. DOI: 10.1371/journal.pmed.1001116 · PMID: 22069379 [Meta-analysis, k=54, n=218,166]And then the number that sums up the article for me. In PREDICT 1 genetic variants contributed 9.5 percent to predicting the glucose response, and 0.8 percent for the blood lipids. Person related factors such as the gut microbiome explained more variance there than the macronutrients of the meal itself.
Put differently: the sensor on your arm can show you more about your metabolism after two weeks than a saliva test.
Three levers that really are individual
- Two weeks with a glucose sensor and an honest log. Not in order to ban foods, but to see which combinations give you flat curves. How this works is described in the article 14 days with a glucose sensor.
- Vary the same test meal. The same breakfast once on its own, once with protein, once after ten minutes of walking. The differences are your personal dataset. The basics are in the article Avoiding blood sugar spikes.
- A few targeted laboratory values instead of many gene markers. Fasting values, HbA1c, blood lipids, ferritin, vitamin D, omega-3 index. These values change with what you do. A genotype does not.
If you would rather not do this on your own: below this article there is the option to arrange an appointment.
Your ancestors helped shape your metabolism. But they are not a source you can question. The source is you, and you are measurable.
And now you know why the most honest answer to the question about the right diet is not in your family tree, but in a curve you can produce yourself.
Common questions about genes, ancestry and nutrition
Are there really carbohydrate types and fat types?
Not as clean categories. The three way split into fat burners, carbohydrate burners and mixed types comes from the marketing of test providers, not from the specialist literature. A peer reviewed primary source that defines and validates these three groups does not exist as far as my research goes. What is documented is something different and finer: single gene variants change single steps in metabolism, for example starch breakdown in saliva or fatty acid oxidation in the mitochondria. But these variants do not add up to two or three types of people.
Does my gene test tell me which diet suits me?
Based on the data we have today, no. Exactly this question was examined in the DIETFITS trial: 609 adults were randomised for twelve months to a low fat or a low carbohydrate diet, and three genotype patterns were defined in advance. The patterns did not predict success, and the interaction between diet and genotype was statistically unremarkable. In the European Food4Me trial with 1,269 people, adding the genotype to personalised advice brought no additional benefit either.
Why can so many people not tolerate milk?
Because switching off lactase production after weaning is the biological default in mammals. The exception is the ability to break down milk sugar as an adult as well. This ability rests on variants in the regulatory region of the lactase gene that arose independently in Europe and in Africa. They are common where people kept livestock over long periods, and rare where that was not the case. Milk intolerance in this sense is therefore not an illness but the more common variant worldwide. Symptoms after dairy products can still be a burden and can have other causes, so a medical assessment may be worth it.
Is it true that people from northern regions burn fat better?
There is no evidence for that as a general north to south rule. What exists are single, very well studied variants in single populations. In circumarctic groups a variant in the fatty acid oxidation regulator CPT1A has become extremely common. But it is not simply an advantage. Looked at on its own it is associated with hypoglycaemia without ketone formation and with increased infant mortality. And selection at the fatty acid desaturases in Europe even ran in the opposite direction to the Inuit. No compass direction rule follows from this.
Why do people of South Asian descent develop type 2 diabetes earlier, even when they are slim?
The pattern is well documented: illness five to ten years earlier and at a lower BMI. But the obvious explanation through genes does not hold. A large review in Lancet Diabetes and Endocrinology states explicitly that there is no clear evidence for a substantial genetic contribution. What is discussed instead is body composition with more visceral fat and less lean mass, lower cardiorespiratory fitness and epigenetic programming. That is why in 2004 the WHO did not set a new uniform BMI cut-off for Asian populations but proposed additional points for action.
What is the AMY1 gene and can I have my copy number tested?
AMY1 is the gene for salivary amylase, the enzyme that starts breaking down starch already in the mouth. Unlike most genes it comes in very different copy numbers, from around one to more than ten copies. Populations with a traditionally starch rich diet have more copies on average. Measuring it is technically possible but of little practical use: the link between copy number and body weight did not hold up when it was re-examined with better measurement technology, and no dietary recommendation can be derived from it.
Why does my face turn red after a glass of wine?
Most likely because the enzyme aldehyde dehydrogenase 2 works more slowly in you. Alcohol is first broken down into acetaldehyde, and this intermediate is then processed further. If this second step is slowed, acetaldehyde can build up, blood vessels can widen and the face turns red. This is not a cosmetic detail. The flush reaction is regarded as a visible marker for a clearly increased risk of oesophageal cancer with regular alcohol consumption. Here the practical consequence is unusually clear.
Is an MTHFR variant a reason for high dose folic acid?
The professional society for medical genetics in the United States published a guideline in 2013 that advises against routine MTHFR testing as part of a thrombophilia workup. The reasoning: newer meta-analyses confirmed neither the link between raised homocysteine and coronary heart disease nor the link between MTHFR status and venous thrombosis. This guideline refers to clotting questions, not to nutrition in general. But it is a good example of how a gene variant can make a career online that the professional societies do not support.
As an APOE4 carrier, should I eat less fat?
No personal recommendation can be derived from the available data. There is a secondary analysis of the British RISCK study with 389 evaluated people in which the APOE genotype was determined afterwards. In it, total cholesterol and apolipoprotein B fell more in E4 carriers when saturated fats were replaced by carbohydrates with a low glycaemic index. The difference was 0.28 mmol/L over 24 weeks. That is a real but small gene and diet interaction in a laboratory value, not in the course of an illness.
As a vegetarian, can I make enough EPA and DHA from linseed oil?
The conversion rate from plant based alpha linolenic acid to EPA and DHA is limited in all people, and it differs on top of that depending on the variant in the FADS genes. A regulatory insertion polymorphism in FADS2 that favours endogenous conversion is present at around 70 percent in South Asian samples and at about 17 percent in European ones. That explains part of the differences but does not replace a measurement. More reliable than an estimate based on ancestry is the omega-3 index in your blood.
What do I get from a DNA nutrition test for 150 to 300 euros?
I deliberately give no recommendation for or against individual providers here, only the state of the evidence. A group of authors from the field of nutrigenetics itself stated in 2017 that the area is unregulated and that beyond individual commercial codes of practice there are no defined standards. A review on precision nutrition names a lack of reproducibility, methodological problems and the still missing proof of additional benefit compared with classical nutrition counselling. What such tests deliver is usually a list of variants with very small effect sizes.
If genes do not help, how do I find out what suits me?
Through measurement in your own body rather than through your family tree. In the PREDICT 1 study with 1,002 people, genetic variants contributed only 9.5 percent to predicting the blood sugar response, and considerably less for blood lipids. At the same time the spread between people after identical meals was enormous. Two weeks with a glucose sensor, an honest food log and a few targeted laboratory values can therefore deliver more personally usable information than a saliva test.
Where this topic can connect
The question of the individual metabolic response comes up again in several areas: with insulin action, with blood sugar, with fatty acids and with training. From here several paths lead onwards.
Understanding insulin resistance
Why the key sometimes no longer fits the lock
Glucose sensor in everyday life
What a CGM can show about your personal curves
Measuring the omega-3 index
The blood value that answers the FADS question in practice
Zone 2 and fat metabolism
How training makes the mitochondrial side trainable
Scientific sources
- Perry GH, Dominy NJ, Claw KG et al. Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007;39(10):1256-60. DOI: 10.1038/ng2123 · PMID: 17828263 [Overview]
- Mandel AL, Breslin PAS. High endogenous salivary amylase activity is associated with improved glycemic homeostasis following starch ingestion in adults. J Nutr. 2012;142(5):853-8. DOI: 10.3945/jn.111.156984 · PMID: 22492122 [RCT, n=14]
- Falchi M, El-Sayed Moustafa JS, Takousis P et al. Low copy number of the salivary amylase gene predisposes to obesity. Nat Genet. 2014;46(5):492-7. DOI: 10.1038/ng.2939 · PMID: 24686848 [Cohort, n=6,200 replication]
- Usher CL, Handsaker RE, Esko T et al. Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. Nat Genet. 2015;47(8):921-5. DOI: 10.1038/ng.3340 · PMID: 26098870 [Cohort, n about 4,500]
- Mejía-Benítez MA, Bonnefond A, Yengo L et al. Beneficial effect of a high number of copies of salivary amylase AMY1 gene on obesity risk in Mexican children. Diabetologia. 2015;58(2):290-4. DOI: 10.1007/s00125-014-3441-3 · PMID: 25394825 [Cohort, n=597 children, case-control design]
- Tishkoff SA, Reed FA, Ranciaro A et al. Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet. 2007;39(1):31-40. DOI: 10.1038/ng1946 · PMID: 17159977 [Overview, n=470]
- Bersaglieri T, Sabeti PC, Patterson N et al. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet. 2004;74(6):1111-20. DOI: 10.1086/421051 · PMID: 15114531 [Overview]
- Ségurel L, Bon C. On the Evolution of Lactase Persistence in Humans. Annu Rev Genomics Hum Genet. 2017;18:297-319. DOI: 10.1146/annurev-genom-091416-035340 · PMID: 28426286 [Systematic Review]
- Evershed RP, Davey Smith G, Roffet-Salque M et al. Dairying, diseases and the evolution of lactase persistence in Europe. Nature. 2022;608(7922):336-345. DOI: 10.1038/s41586-022-05010-7 · PMID: 35896751 [Cohort, UK Biobank, plus archaeometric analysis]
- Clemente FJ, Cardona A, Inchley CE et al. A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations. Am J Hum Genet. 2014;95(5):584-589. DOI: 10.1016/j.ajhg.2014.09.016 · PMID: 25449608 [Overview]
- Moltke I, Grarup N, Jørgensen ME et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature. 2014;512(7513):190-3. DOI: 10.1038/nature13425 · PMID: 25043022 [Cohort, n up to 2,575]
- Fumagalli M, Moltke I, Grarup N et al. Greenlandic Inuit show genetic signatures of diet and climate adaptation. Science. 2015;349(6254):1343-7. DOI: 10.1126/science.aab2319 · PMID: 26383953 [Overview]
- Fodor JG, Helis E, Yazdekhasti N, Vohnout B. Fishing for the origins of the Eskimos and heart disease story: facts or wishful thinking? Can J Cardiol. 2014;30(8):864-8. DOI: 10.1016/j.cjca.2014.04.007 · PMID: 25064579 [Systematic Review]
- Ameur A, Enroth S, Johansson Å et al. Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am J Hum Genet. 2012;90(5):809-20. DOI: 10.1016/j.ajhg.2012.03.014 · PMID: 22503634 [Cohort, n=5,652]
- Kothapalli KSD, Ye K, Gadgil MS et al. Positive Selection on a Regulatory Insertion-Deletion Polymorphism in FADS2 Influences Apparent Endogenous Synthesis of Arachidonic Acid. Mol Biol Evol. 2016;33(7):1726-39. DOI: 10.1093/molbev/msw049 · PMID: 27188529 [Cohort, n=545]
- Buckley MT, Racimo F, Allentoft ME et al. Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes. Mol Biol Evol. 2017;34(6):1307-1318. DOI: 10.1093/molbev/msx103 · PMID: 28333262 [Overview]
- Mathieson I, Lazaridis I, Rohland N et al. Genome-wide patterns of selection in 230 ancient Eurasians. Nature. 2015;528(7583):499-503. DOI: 10.1038/nature16152 · PMID: 26595274 [Overview, n=230]
- Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med. 2009;6(3):e50. DOI: 10.1371/journal.pmed.1000050 · PMID: 19320537 [Overview]
- Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013;15(2):153-6. DOI: 10.1038/gim.2012.165 · PMID: 23288205 [Agency Document]
- Griffin BA, Walker CG, Jebb SA et al. APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates. Nutrients. 2018;10(10):1524. DOI: 10.3390/nu10101524 · PMID: 30336580 [RCT, n=389, secondary analysis]
- Rosenberg NA, Pritchard JK, Weber JL et al. Genetic structure of human populations. Science. 2002;298(5602):2381-5. DOI: 10.1126/science.1078311 · PMID: 12493913 [Overview, n=1,056]
- Sattar N, Gill JMR. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol. 2015;3(12):1004-16. DOI: 10.1016/S2213-8587(15)00326-5 · PMID: 26489808 [Systematic Review]
- WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3 · PMID: 14726171 [Agency Document]
- Kodama K, Tojjar D, Yamada S et al. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36(6):1789-96. DOI: 10.2337/dc12-1235 · PMID: 23704681 [Meta-analysis, k=74, n=3,813]
- Rothschild D, Weissbrod O, Barkan E et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210-215. DOI: 10.1038/nature25973 · PMID: 29489753 [Cohort, n=1,046]
- Gardner CD, Trepanowski JF, Del Gobbo LC et al. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial. JAMA. 2018;319(7):667-679. DOI: 10.1001/jama.2018.0245 · PMID: 29466592 [RCT, n=609]
- Celis-Morales C, Livingstone KM, Marsaux CFM et al. Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial. Int J Epidemiol. 2017;46(2):578-588. DOI: 10.1093/ije/dyw186 · PMID: 27524815 [RCT, n=1,269]
- Grimaldi KA, van Ommen B, Ordovas JM et al. Proposed guidelines to evaluate scientific validity and evidence for genotype-based dietary advice. Genes Nutr. 2017;12:35. DOI: 10.1186/s12263-017-0584-0 · PMID: 29270237 [Overview]
- Wang DD, Hu FB. Precision nutrition for prevention and management of type 2 diabetes. Lancet Diabetes Endocrinol. 2018;6(5):416-426. DOI: 10.1016/S2213-8587(18)30037-8 · PMID: 29433995 [Systematic Review]
- Zeevi D, Korem T, Zmora N et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079-1094. DOI: 10.1016/j.cell.2015.11.001 · PMID: 26590418 [Cohort, n=800, with a small randomised phase]
- Berry SE, Valdes AM, Drew DA et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020;26(6):964-973. DOI: 10.1038/s41591-020-0934-0 · PMID: 32528151 [Cohort, n=1,002 plus n=100 validation]
- Kilpeläinen TO, Qi L, Brage S et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11):e1001116. DOI: 10.1371/journal.pmed.1001116 · PMID: 22069379 [Meta-analysis, k=54, n=218,166]